Skip to main content
Clinical Trials/IRCT20200105046010N27
IRCT20200105046010N27Not yet recruiting未知

In- Vivo Bioequivalence study of Rivaroxaban tablet 10 and 20mg Jaber-ebne Hayyan Pharma with brand drug (XARELTO® 10 and 20mg Bayer, Germany) in Iranian healthy volunteers.

Jaber Ibn Hayyan Pharmaceutical Company0 sites24 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
24